As mentioned above, the increased production of ROS via NADPH oxidase in diabetes is attributed to the activation of the NF-κB pathway, which also promotes the transcriptional activation of the genes encoding inflammatory cytokines, thereby contributing to kidney injury and leading to renal fibrosis and a decline in renal function [56,57,58]. The gene discussed is FMO5; the disease is diabetes mellitus.